Powered by

CareStart™ COVID-19 Antigen test kit using NanoAct™ launched in the U.S.

Dec 08, 2020 - PR Newswire

PR Newswire

CareStart™ COVID-19 Antigen test kit developed by Access Bio, Inc., using Asahi Kasei's NanoAct™ cellulose nanobeads, received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), and its sale in the U.S. has begun.

NanoAct™ colored cellulose nanobeads were developed by Asahi Kasei by utilizing its core technology of cellulose processing.  They are currently used as labels for lateral flow immunochromatographic assays, m...